30 June 2020: Clinical Research
Application of the Molecular Adsorbent Recirculating System in Type 1 Hepatorenal Syndrome in the Course of Alcohol-Related Acute on Chronic Liver Failure
Grzegorz Kade 1ABCEF , Arkadiusz Lubas 1ACDEF , Sebastian Spaleniak 2ADEF* , Anna Wojtecka 1B , Ksymena Leśniak 1B , Sławomir Literacki 3BF , Stanisław Niemczyk 1E , Przemysław Dyrla 4BCDEDOI: 10.12659/MSM.923805
Med Sci Monit 2020; 26:e923805
Table 1 Clinical characteristics of the studied group.
| Variable | Mean | Median | Minimum | Maximum | SD |
|---|---|---|---|---|---|
| Age (year) | 52.1 | 55.0 | 31.0 | 64.0 | 11.1 |
| Time to discharge or death (day) | 20.5 | 17.0 | 3.0 | 45.0 | 13.9 |
| Natrium (mmol/L) | 135.1 | 136.0 | 129.0 | 143.0 | 4.33 |
| Potassium (mmol/L) | 4.1 | 3.8 | 3.5 | 5.3 | 0.6 |
| Bilirubin (mg/dL) | 28.2 | 30.2 | 17.6 | 38.6 | 7.48 |
| Ammonia (μmol/L) | 49.9 | 45.5 | 22.0 | 92.0 | 25.04 |
| Creatinine (mg/dL) | 1.85 | 1.20 | 0.70 | 4.20 | 1.26 |
| Urea (mg/dL) | 92.8 | 94.5 | 32.0 | 182.0 | 42.7 |
| Albumin (g/dL) | 2.9 | 2.9 | 2.2 | 3.5 | 0.4 |
| MELD-Na – pre | 34.9 | 35.0 | 28.0 | 44.0 | 5.2 |
| MELD-Na – post | 35.1 | 35.0 | 23.0 | 44.0 | 6.9 |
| MARS/patient | 4.0 | 3.5 | 1.0 | 9.0 | 2.2 |
| West Haven – pre | 1.6 | 1.0 | 1.0 | 3.0 | 0.8 |
| West Haven – post | 1.1 | 0.5 | 0.0 | 4.0 | 1.4 |
| MARS – Molecular Adsorbent Recirculating System; MELD-Na pre/post – model for end-stage liver disease – sodium scale score before or after MARS treatment; West Haven pre/post – West Haven scale score before or after MARS treatment; SD – standard deviation. | |||||